Editorial articles
January 2004 Br J Cardiol 2004;11:16-21
Omega-3 polyunsaturated fatty acids: mechanisms and clinical applications explored
BJCardio editorial team
A joint British Journal of Cardiology and H.E.A.R.T UK round table meeting held at the National Heart and Lung Institute, 18th November 2003.
January 2004 Br J Cardiol 2004;11:5-7
Cardiac pathology – a dying trade?
Mary N Sheppard
It seems ironic that, at a time of ultra-specialisation, when
the public is demanding higher standards from doctors,
academic medicine is being downgraded. Cardiac pathology
represents a perfect case in point.
November 2003 Br J Cardiol 2003;10:428-30
Training in cardiology – the next decade
John Greenwood
The introduction of the first specialist registrar training programme in December 1995 brought a radical overhaul in higher specialist training. Each speciality produced a curriculum establishing specific training objectives against which the progress of an individual trainee could be judged.
November 2003 Br J Cardiol 2003;10:426-7
BANCC: the changing role of the cardiac nurse
Debbie Hughes
The traditional role of the cardiac nurse, particularly at the inception of the coronary care unit (CCU), has been evolving since the early 60s.
November 2003 Br J Cardiol 2003;10:424-5
Rehabilitation: quantity and quality will count
J Malcolm Walker
Cardiac rehabilitation has historically been an underdeveloped service in the UK. It is now recognised as an essential component in the management of heart disease and will shortly encompass those at risk of developing cardiovascular disorders.
November 2003 Br J Cardiol 2003;10:421-3
NHA: the evolving role of the nurse in hypertension
Susan Kennedy
Hypertension is one of the major risk factors for vascular disease and its treatment to target requires not only careful monitoring with lifestyle advice and pharmacological intervention but also a good understanding of the condition by the patient.
November 2003 Br J Cardiol 2003;10:418-20
Prospects for hypertension in the next decade
Neil R Poulter
During the second half of the twentieth century our knowledge of the aetiology of and pathophysiological mechanisms underlying hypertension have advanced immeasurably. Furthermore, few, if any, areas of medicine have as many major morbidity and mortality trials to inform optimal management as does hypertension.
November 2003 Br J Cardiol 2003;10:416-7
H.E.A.R.T UK: hyperlipidaemia and the challenges ahead
Julie Foxton, Anthony Wierzbicki, John Reckless
The merits of reducing cholesterol to help prevent coronary heart disease (CHD) were questioned 10 years ago. There were great debates about the utility of reducing low-density lipoprotein cholesterol (LDL-C) and it is now clear, following the publication of at least eight different clinical drug trials, that reducing cholesterol with statin drugs helps to reduce total mortality, cardiovascular mortality and morbidity and interventional procedures.
November 2003 Br J Cardiol 2003;10:414-5
PCCS: critical thinking for times ahead
Fran Sivers
The Primary Care Cardiovascular Society (PCCS) has come a long way since a small group of us met in an inauspicious hotel in middle England in the mid 1990s, to discuss the formation of a group through which to develop a network of general practitioners (GPs) with a particular interest in cardiovascular disease and its management.
November 2003 Br J Cardiol 2003;10:412-3
Department of Health reports NSF key targets are being delivered ahead of schedule
Roger Boyle
Ten years ago, England had one of the worst death rates from circulatory diseases in Europe. Today, thanks to the expertise and hard work of thousands of NHS staff, major progress has been made in implementing the National Service Framework (NSF) for Coronary Heart Disease (CHD), and deaths from circulatory diseases are set to be reduced by 40%, three years ahead of the 10-year target set when the NSF was published in March 2000. As a result, we estimate that around 100,000 lives are being saved each year.
